Doubts Raised About Off-Label Use of Subsys, a Strong Painkiller
The drug was approved in 2012 for cancer patients, but has since become an outsize moneymaker for Insys Therapeutics and has been prescribed more widely. [Source]
Publication Date:Origin: nytimes.com
Category: Regulation and Deregulation of Industry
Topics: widely, prescribed, Therapeutics, Insys, moneymaker, outsize, become, since, patients, cancer, approved, Painkiller, Strong, Subsys, Off-Label, About, Raised, Doubts